nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—ABCG2—Topotecan—cervical cancer	0.388	0.735	CbGbCtD
Cisplatin—ABCB1—Topotecan—cervical cancer	0.14	0.265	CbGbCtD
Cisplatin—Metastatic neoplasm—Topotecan—cervical cancer	0.0194	0.172	CcSEcCtD
Cisplatin—Acute leukaemia—Topotecan—cervical cancer	0.013	0.115	CcSEcCtD
Cisplatin—SLC31A2—exocrine gland—cervical cancer	0.00967	0.0344	CbGeAlD
Cisplatin—Myelosuppression—Topotecan—cervical cancer	0.00795	0.0703	CcSEcCtD
Cisplatin—Febrile neutropenia—Topotecan—cervical cancer	0.00619	0.0548	CcSEcCtD
Cisplatin—MT1A—renal system—cervical cancer	0.00477	0.0169	CbGeAlD
Cisplatin—GSTP1—exocrine gland—cervical cancer	0.00444	0.0158	CbGeAlD
Cisplatin—CYP4A11—renal system—cervical cancer	0.00439	0.0156	CbGeAlD
Cisplatin—Extravasation—Topotecan—cervical cancer	0.00427	0.0378	CcSEcCtD
Cisplatin—SLC31A2—uterine cervix—cervical cancer	0.00417	0.0148	CbGeAlD
Cisplatin—ATP7B—endometrium—cervical cancer	0.00413	0.0147	CbGeAlD
Cisplatin—SLC31A2—decidua—cervical cancer	0.00397	0.0141	CbGeAlD
Cisplatin—MT2A—renal system—cervical cancer	0.00397	0.0141	CbGeAlD
Cisplatin—GSTT1—renal system—cervical cancer	0.00389	0.0138	CbGeAlD
Cisplatin—MT1A—female reproductive system—cervical cancer	0.00382	0.0136	CbGeAlD
Cisplatin—ATP7B—uterus—cervical cancer	0.0038	0.0135	CbGeAlD
Cisplatin—SLC31A2—endometrium—cervical cancer	0.00377	0.0134	CbGeAlD
Cisplatin—ATP7A—epithelium—cervical cancer	0.00371	0.0132	CbGeAlD
Cisplatin—ATP7A—uterine cervix—cervical cancer	0.00367	0.0131	CbGeAlD
Cisplatin—SLC31A2—mammalian vulva—cervical cancer	0.00365	0.013	CbGeAlD
Cisplatin—ATP7A—decidua—cervical cancer	0.0035	0.0124	CbGeAlD
Cisplatin—Neuropathy—Topotecan—cervical cancer	0.0035	0.0309	CcSEcCtD
Cisplatin—ATP7A—renal system—cervical cancer	0.00344	0.0122	CbGeAlD
Cisplatin—ATP7B—female reproductive system—cervical cancer	0.00342	0.0122	CbGeAlD
Cisplatin—SOD1—Validated nuclear estrogen receptor alpha network—POU4F1—cervical cancer	0.00341	0.0439	CbGpPWpGaD
Cisplatin—ATP7A—endometrium—cervical cancer	0.00332	0.0118	CbGeAlD
Cisplatin—SOD1—uterine cervix—cervical cancer	0.00322	0.0114	CbGeAlD
Cisplatin—ATP7A—mammalian vulva—cervical cancer	0.00321	0.0114	CbGeAlD
Cisplatin—CYP4A11—vagina—cervical cancer	0.00318	0.0113	CbGeAlD
Cisplatin—MT2A—female reproductive system—cervical cancer	0.00318	0.0113	CbGeAlD
Cisplatin—ABCC6—renal system—cervical cancer	0.00315	0.0112	CbGeAlD
Cisplatin—SLC31A1—uterine cervix—cervical cancer	0.00313	0.0111	CbGeAlD
Cisplatin—SLC31A2—female reproductive system—cervical cancer	0.00312	0.0111	CbGeAlD
Cisplatin—ATP7B—female gonad—cervical cancer	0.00311	0.0111	CbGeAlD
Cisplatin—GSTT1—female reproductive system—cervical cancer	0.00311	0.0111	CbGeAlD
Cisplatin—XDH—uterine cervix—cervical cancer	0.0031	0.011	CbGeAlD
Cisplatin—ATP7B—vagina—cervical cancer	0.00309	0.011	CbGeAlD
Cisplatin—SOD1—decidua—cervical cancer	0.00306	0.0109	CbGeAlD
Cisplatin—SLC31A1—renal system—cervical cancer	0.00293	0.0104	CbGeAlD
Cisplatin—SOD1—endometrium—cervical cancer	0.00291	0.0103	CbGeAlD
Cisplatin—XDH—renal system—cervical cancer	0.0029	0.0103	CbGeAlD
Cisplatin—MT2A—female gonad—cervical cancer	0.00289	0.0103	CbGeAlD
Cisplatin—GSTM1—renal system—cervical cancer	0.00286	0.0102	CbGeAlD
Cisplatin—SLC31A2—female gonad—cervical cancer	0.00284	0.0101	CbGeAlD
Cisplatin—SLC31A1—endometrium—cervical cancer	0.00283	0.0101	CbGeAlD
Cisplatin—SLC31A2—vagina—cervical cancer	0.00283	0.01	CbGeAlD
Cisplatin—GSTM1—C-MYB transcription factor network—PIAS3—cervical cancer	0.00281	0.0363	CbGpPWpGaD
Cisplatin—SOD1—mammalian vulva—cervical cancer	0.00281	0.01	CbGeAlD
Cisplatin—XDH—endometrium—cervical cancer	0.0028	0.00995	CbGeAlD
Cisplatin—Anaphylactoid reaction—Topotecan—cervical cancer	0.00279	0.0247	CcSEcCtD
Cisplatin—SLC31A1—mammalian vulva—cervical cancer	0.00274	0.00974	CbGeAlD
Cisplatin—XDH—mammalian vulva—cervical cancer	0.00271	0.00963	CbGeAlD
Cisplatin—SOD1—uterus—cervical cancer	0.00268	0.00953	CbGeAlD
Cisplatin—ATP7A—female gonad—cervical cancer	0.00251	0.0089	CbGeAlD
Cisplatin—ATP7A—vagina—cervical cancer	0.00249	0.00885	CbGeAlD
Cisplatin—Cramp muscle—Topotecan—cervical cancer	0.00244	0.0215	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.00244	0.0215	CcSEcCtD
Cisplatin—MPO—C-MYB transcription factor network—PIAS3—cervical cancer	0.00239	0.0308	CbGpPWpGaD
Cisplatin—SLC31A2—Copper homeostasis—CASP3—cervical cancer	0.00239	0.0308	CbGpPWpGaD
Cisplatin—SLC31A1—female reproductive system—cervical cancer	0.00235	0.00835	CbGeAlD
Cisplatin—XDH—female reproductive system—cervical cancer	0.00232	0.00824	CbGeAlD
Cisplatin—GSTM1—female reproductive system—cervical cancer	0.00229	0.00815	CbGeAlD
Cisplatin—ABCC5—uterine cervix—cervical cancer	0.00229	0.00814	CbGeAlD
Cisplatin—SLC22A2—renal system—cervical cancer	0.00227	0.00807	CbGeAlD
Cisplatin—MT1A—lymph node—cervical cancer	0.00223	0.00794	CbGeAlD
Cisplatin—Pancytopenia—Topotecan—cervical cancer	0.00222	0.0196	CcSEcCtD
Cisplatin—SOD1—female gonad—cervical cancer	0.00219	0.00779	CbGeAlD
Cisplatin—ABCC5—decidua—cervical cancer	0.00218	0.00776	CbGeAlD
Cisplatin—SOD1—vagina—cervical cancer	0.00218	0.00774	CbGeAlD
Cisplatin—NQO1—epithelium—cervical cancer	0.00216	0.00769	CbGeAlD
Cisplatin—NQO1—uterine cervix—cervical cancer	0.00214	0.00762	CbGeAlD
Cisplatin—SLC31A1—female gonad—cervical cancer	0.00214	0.00759	CbGeAlD
Cisplatin—SLC31A1—vagina—cervical cancer	0.00212	0.00755	CbGeAlD
Cisplatin—XDH—vagina—cervical cancer	0.0021	0.00746	CbGeAlD
Cisplatin—GSTM1—female gonad—cervical cancer	0.00209	0.00741	CbGeAlD
Cisplatin—Neuropathy peripheral—Topotecan—cervical cancer	0.00204	0.0181	CcSEcCtD
Cisplatin—NQO1—decidua—cervical cancer	0.00204	0.00726	CbGeAlD
Cisplatin—Stomatitis—Topotecan—cervical cancer	0.00203	0.018	CcSEcCtD
Cisplatin—NQO1—renal system—cervical cancer	0.00201	0.00713	CbGeAlD
Cisplatin—ATP7B—lymph node—cervical cancer	0.002	0.00711	CbGeAlD
Cisplatin—MPO—epithelium—cervical cancer	0.00199	0.00707	CbGeAlD
Cisplatin—Hepatobiliary disease—Topotecan—cervical cancer	0.00197	0.0174	CcSEcCtD
Cisplatin—NQO1—endometrium—cervical cancer	0.00194	0.00689	CbGeAlD
Cisplatin—GSTP1—epithelium—cervical cancer	0.00193	0.00687	CbGeAlD
Cisplatin—MT2A—Interferon gamma signaling—HLA-DPB1—cervical cancer	0.00193	0.0249	CbGpPWpGaD
Cisplatin—GSTP1—uterine cervix—cervical cancer	0.00192	0.00681	CbGeAlD
Cisplatin—CYP4A11—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00188	0.0243	CbGpPWpGaD
Cisplatin—NQO1—mammalian vulva—cervical cancer	0.00188	0.00667	CbGeAlD
Cisplatin—MPO—renal system—cervical cancer	0.00184	0.00655	CbGeAlD
Cisplatin—ABCC3—decidua—cervical cancer	0.00183	0.00652	CbGeAlD
Cisplatin—SLC31A2—lymph node—cervical cancer	0.00183	0.0065	CbGeAlD
Cisplatin—GSTP1—decidua—cervical cancer	0.00183	0.00649	CbGeAlD
Cisplatin—ABCC3—renal system—cervical cancer	0.0018	0.0064	CbGeAlD
Cisplatin—GSTP1—renal system—cervical cancer	0.00179	0.00637	CbGeAlD
Cisplatin—NQO1—uterus—cervical cancer	0.00179	0.00635	CbGeAlD
Cisplatin—GSTP1—endometrium—cervical cancer	0.00173	0.00616	CbGeAlD
Cisplatin—Immune system disorder—Topotecan—cervical cancer	0.00169	0.015	CcSEcCtD
Cisplatin—Mediastinal disorder—Topotecan—cervical cancer	0.00169	0.0149	CcSEcCtD
Cisplatin—GSTP1—mammalian vulva—cervical cancer	0.00168	0.00596	CbGeAlD
Cisplatin—Alopecia—Topotecan—cervical cancer	0.00165	0.0146	CcSEcCtD
Cisplatin—Malnutrition—Topotecan—cervical cancer	0.00163	0.0144	CcSEcCtD
Cisplatin—ATP7A—lymph node—cervical cancer	0.00161	0.00572	CbGeAlD
Cisplatin—NQO1—female reproductive system—cervical cancer	0.00161	0.00571	CbGeAlD
Cisplatin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.0016	0.0206	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.0016	0.0206	CbGpPWpGaD
Cisplatin—GSTP1—uterus—cervical cancer	0.0016	0.00568	CbGeAlD
Cisplatin—Muscle spasms—Topotecan—cervical cancer	0.00157	0.0139	CcSEcCtD
Cisplatin—ABCC5—female gonad—cervical cancer	0.00156	0.00555	CbGeAlD
Cisplatin—ABCC5—vagina—cervical cancer	0.00155	0.00552	CbGeAlD
Cisplatin—MT1A—Copper homeostasis—CASP3—cervical cancer	0.00154	0.0198	CbGpPWpGaD
Cisplatin—SLC31A2—Copper homeostasis—TP53—cervical cancer	0.00153	0.0197	CbGpPWpGaD
Cisplatin—ABCC5—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00152	0.0196	CbGpPWpGaD
Cisplatin—Ill-defined disorder—Topotecan—cervical cancer	0.00151	0.0134	CcSEcCtD
Cisplatin—MT2A—Interferon gamma signaling—HLA-DQB1—cervical cancer	0.00151	0.0194	CbGpPWpGaD
Cisplatin—Anaemia—Topotecan—cervical cancer	0.00151	0.0133	CcSEcCtD
Cisplatin—Malaise—Topotecan—cervical cancer	0.00147	0.013	CcSEcCtD
Cisplatin—NQO1—female gonad—cervical cancer	0.00146	0.00519	CbGeAlD
Cisplatin—Leukopenia—Topotecan—cervical cancer	0.00146	0.0129	CcSEcCtD
Cisplatin—NQO1—vagina—cervical cancer	0.00145	0.00516	CbGeAlD
Cisplatin—ABCC3—female reproductive system—cervical cancer	0.00144	0.00512	CbGeAlD
Cisplatin—ABCC2—renal system—cervical cancer	0.00144	0.00511	CbGeAlD
Cisplatin—GSTP1—female reproductive system—cervical cancer	0.00144	0.0051	CbGeAlD
Cisplatin—SOD1—lymph node—cervical cancer	0.00141	0.00501	CbGeAlD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.0014	0.018	CbGpPWpGaD
Cisplatin—Myalgia—Topotecan—cervical cancer	0.00139	0.0123	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00138	0.0122	CcSEcCtD
Cisplatin—SLC31A1—lymph node—cervical cancer	0.00137	0.00488	CbGeAlD
Cisplatin—Discomfort—Topotecan—cervical cancer	0.00137	0.0121	CcSEcCtD
Cisplatin—GSTM1—lymph node—cervical cancer	0.00134	0.00476	CbGeAlD
Cisplatin—Anaphylactic shock—Topotecan—cervical cancer	0.00133	0.0118	CcSEcCtD
Cisplatin—Infection—Topotecan—cervical cancer	0.00132	0.0117	CcSEcCtD
Cisplatin—ABCC3—female gonad—cervical cancer	0.00131	0.00466	CbGeAlD
Cisplatin—GSTP1—female gonad—cervical cancer	0.00131	0.00464	CbGeAlD
Cisplatin—Nervous system disorder—Topotecan—cervical cancer	0.0013	0.0115	CcSEcCtD
Cisplatin—Thrombocytopenia—Topotecan—cervical cancer	0.0013	0.0115	CcSEcCtD
Cisplatin—GSTP1—vagina—cervical cancer	0.0013	0.00461	CbGeAlD
Cisplatin—Skin disorder—Topotecan—cervical cancer	0.00129	0.0114	CcSEcCtD
Cisplatin—Hyperhidrosis—Topotecan—cervical cancer	0.00129	0.0114	CcSEcCtD
Cisplatin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00127	0.0164	CbGpPWpGaD
Cisplatin—Anorexia—Topotecan—cervical cancer	0.00127	0.0112	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00121	0.0107	CcSEcCtD
Cisplatin—Paraesthesia—Topotecan—cervical cancer	0.00119	0.0106	CcSEcCtD
Cisplatin—Dyspnoea—Topotecan—cervical cancer	0.00119	0.0105	CcSEcCtD
Cisplatin—ATP7B—Copper homeostasis—CASP3—cervical cancer	0.00117	0.015	CbGpPWpGaD
Cisplatin—BCHE—uterine cervix—cervical cancer	0.00116	0.00412	CbGeAlD
Cisplatin—Decreased appetite—Topotecan—cervical cancer	0.00116	0.0102	CcSEcCtD
Cisplatin—ABCC2—female reproductive system—cervical cancer	0.00115	0.00409	CbGeAlD
Cisplatin—Gastrointestinal disorder—Topotecan—cervical cancer	0.00115	0.0102	CcSEcCtD
Cisplatin—Pain—Topotecan—cervical cancer	0.00114	0.0101	CcSEcCtD
Cisplatin—ATP7A—Cellular responses to stress—CA9—cervical cancer	0.00113	0.0145	CbGpPWpGaD
Cisplatin—ABCG2—uterine cervix—cervical cancer	0.00112	0.00398	CbGeAlD
Cisplatin—ABCC3—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.00112	0.0144	CbGpPWpGaD
Cisplatin—Feeling abnormal—Topotecan—cervical cancer	0.0011	0.00969	CcSEcCtD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.00108	0.0139	CbGpPWpGaD
Cisplatin—ABCG2—decidua—cervical cancer	0.00107	0.0038	CbGeAlD
Cisplatin—ABCC5—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00106	0.0137	CbGpPWpGaD
Cisplatin—Body temperature increased—Topotecan—cervical cancer	0.00105	0.0093	CcSEcCtD
Cisplatin—BCHE—endometrium—cervical cancer	0.00105	0.00373	CbGeAlD
Cisplatin—SOD1—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.00103	0.0132	CbGpPWpGaD
Cisplatin—BCHE—mammalian vulva—cervical cancer	0.00102	0.00361	CbGeAlD
Cisplatin—ABCG2—endometrium—cervical cancer	0.00101	0.0036	CbGeAlD
Cisplatin—ABCC5—lymph node—cervical cancer	0.001	0.00357	CbGeAlD
Cisplatin—ATP7A—Copper homeostasis—CASP3—cervical cancer	0.000993	0.0128	CbGpPWpGaD
Cisplatin—MT1A—Copper homeostasis—TP53—cervical cancer	0.000988	0.0127	CbGpPWpGaD
Cisplatin—ABCG2—mammalian vulva—cervical cancer	0.000981	0.00349	CbGeAlD
Cisplatin—Hypersensitivity—Topotecan—cervical cancer	0.000979	0.00866	CcSEcCtD
Cisplatin—CYP2B6—renal system—cervical cancer	0.000968	0.00344	CbGeAlD
Cisplatin—BCHE—uterus—cervical cancer	0.000967	0.00344	CbGeAlD
Cisplatin—Asthenia—Topotecan—cervical cancer	0.000954	0.00844	CcSEcCtD
Cisplatin—SLC31A1—Copper homeostasis—CASP3—cervical cancer	0.000952	0.0123	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—HLA-DPB1—cervical cancer	0.000942	0.0121	CbGpPWpGaD
Cisplatin—NQO1—lymph node—cervical cancer	0.00094	0.00334	CbGeAlD
Cisplatin—ABCG2—uterus—cervical cancer	0.000935	0.00332	CbGeAlD
Cisplatin—MT2A—Copper homeostasis—CASP3—cervical cancer	0.000933	0.012	CbGpPWpGaD
Cisplatin—Diarrhoea—Topotecan—cervical cancer	0.00091	0.00805	CcSEcCtD
Cisplatin—PTGS2—epithelium—cervical cancer	0.000902	0.0032	CbGeAlD
Cisplatin—MPO—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.000894	0.0115	CbGpPWpGaD
Cisplatin—PTGS2—uterine cervix—cervical cancer	0.000894	0.00318	CbGeAlD
Cisplatin—BCHE—female reproductive system—cervical cancer	0.000869	0.00309	CbGeAlD
Cisplatin—MPO—lymph node—cervical cancer	0.000864	0.00307	CbGeAlD
Cisplatin—Vomiting—Topotecan—cervical cancer	0.000845	0.00748	CcSEcCtD
Cisplatin—ABCC3—lymph node—cervical cancer	0.000843	0.003	CbGeAlD
Cisplatin—GSTP1—lymph node—cervical cancer	0.00084	0.00298	CbGeAlD
Cisplatin—Rash—Topotecan—cervical cancer	0.000838	0.00741	CcSEcCtD
Cisplatin—Dermatitis—Topotecan—cervical cancer	0.000837	0.00741	CcSEcCtD
Cisplatin—PTGS2—renal system—cervical cancer	0.000836	0.00297	CbGeAlD
Cisplatin—SOD1—Folate Metabolism—MTHFR—cervical cancer	0.000834	0.0107	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—SERPIND1—cervical cancer	0.000825	0.0106	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—GP6—cervical cancer	0.000825	0.0106	CbGpPWpGaD
Cisplatin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000809	0.0104	CbGpPWpGaD
Cisplatin—PTGS2—endometrium—cervical cancer	0.000808	0.00287	CbGeAlD
Cisplatin—GSTM1—C-MYB transcription factor network—HES1—cervical cancer	0.000803	0.0103	CbGpPWpGaD
Cisplatin—Nausea—Topotecan—cervical cancer	0.00079	0.00698	CcSEcCtD
Cisplatin—BCHE—vagina—cervical cancer	0.000786	0.00279	CbGeAlD
Cisplatin—ABCC3—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000783	0.0101	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—PIAS3—cervical cancer	0.000778	0.01	CbGpPWpGaD
Cisplatin—CYP2B6—female reproductive system—cervical cancer	0.000775	0.00275	CbGeAlD
Cisplatin—ABCG2—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000772	0.00994	CbGpPWpGaD
Cisplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—CASP3—cervical cancer	0.000768	0.0099	CbGpPWpGaD
Cisplatin—CYP2C9—female reproductive system—cervical cancer	0.000768	0.00273	CbGeAlD
Cisplatin—ABCG2—female gonad—cervical cancer	0.000764	0.00272	CbGeAlD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000764	0.00984	CbGpPWpGaD
Cisplatin—ABCG2—vagina—cervical cancer	0.00076	0.0027	CbGeAlD
Cisplatin—ATP7B—Copper homeostasis—TP53—cervical cancer	0.000749	0.00964	CbGpPWpGaD
Cisplatin—PTGS2—uterus—cervical cancer	0.000745	0.00265	CbGeAlD
Cisplatin—MPO—IL23-mediated signaling events—CD4—cervical cancer	0.000743	0.00957	CbGpPWpGaD
Cisplatin—MT2A—Interferon Signaling—HLA-DQB1—cervical cancer	0.000736	0.00948	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—MTHFR—cervical cancer	0.000728	0.00938	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—GP5—cervical cancer	0.000721	0.00929	CbGpPWpGaD
Cisplatin—MT2A—AP-1 transcription factor network—CTNNB1—cervical cancer	0.000709	0.00914	CbGpPWpGaD
Cisplatin—CYP2B6—vagina—cervical cancer	0.000701	0.00249	CbGeAlD
Cisplatin—MPO—C-MYB transcription factor network—HES1—cervical cancer	0.000683	0.0088	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—CA9—cervical cancer	0.000678	0.00873	CbGpPWpGaD
Cisplatin—ABCC2—lymph node—cervical cancer	0.000674	0.00239	CbGeAlD
Cisplatin—PTGS2—female reproductive system—cervical cancer	0.00067	0.00238	CbGeAlD
Cisplatin—SOD1—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000663	0.00854	CbGpPWpGaD
Cisplatin—SOD1—AGE/RAGE pathway—CASP8—cervical cancer	0.000653	0.00841	CbGpPWpGaD
Cisplatin—ATP7A—Copper homeostasis—TP53—cervical cancer	0.000636	0.0082	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HLA-DPB1—cervical cancer	0.000629	0.00811	CbGpPWpGaD
Cisplatin—SLC31A1—Copper homeostasis—TP53—cervical cancer	0.00061	0.00786	CbGpPWpGaD
Cisplatin—PTGS2—female gonad—cervical cancer	0.000609	0.00217	CbGeAlD
Cisplatin—PTGS2—vagina—cervical cancer	0.000606	0.00215	CbGeAlD
Cisplatin—MT2A—Copper homeostasis—TP53—cervical cancer	0.000598	0.00771	CbGpPWpGaD
Cisplatin—SOD1—Copper homeostasis—CASP3—cervical cancer	0.000598	0.0077	CbGpPWpGaD
Cisplatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000597	0.00769	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—CA9—cervical cancer	0.000592	0.00762	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000578	0.00745	CbGpPWpGaD
Cisplatin—MPO—IL23-mediated signaling events—STAT3—cervical cancer	0.000575	0.00741	CbGpPWpGaD
Cisplatin—ABCB1—epithelium—cervical cancer	0.000558	0.00198	CbGeAlD
Cisplatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000558	0.00718	CbGpPWpGaD
Cisplatin—ABCB1—uterine cervix—cervical cancer	0.000553	0.00196	CbGeAlD
Cisplatin—ABCG2—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.00054	0.00695	CbGpPWpGaD
Cisplatin—ABCB1—decidua—cervical cancer	0.000527	0.00187	CbGeAlD
Cisplatin—ABCB1—renal system—cervical cancer	0.000517	0.00184	CbGeAlD
Cisplatin—BCHE—lymph node—cervical cancer	0.000509	0.00181	CbGeAlD
Cisplatin—XDH—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000505	0.00651	CbGpPWpGaD
Cisplatin—ABCB1—endometrium—cervical cancer	0.0005	0.00178	CbGeAlD
Cisplatin—SOD1—AGE/RAGE pathway—CASP3—cervical cancer	0.000494	0.00636	CbGpPWpGaD
Cisplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TP53—cervical cancer	0.000492	0.00634	CbGpPWpGaD
Cisplatin—ABCG2—lymph node—cervical cancer	0.000491	0.00175	CbGeAlD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HLA-DQB1—cervical cancer	0.000491	0.00633	CbGpPWpGaD
Cisplatin—ABCB1—mammalian vulva—cervical cancer	0.000484	0.00172	CbGeAlD
Cisplatin—MT2A—AP-1 transcription factor network—TP53—cervical cancer	0.000472	0.00608	CbGpPWpGaD
Cisplatin—ABCB1—uterus—cervical cancer	0.000461	0.00164	CbGeAlD
Cisplatin—GSTM1—C-MYB transcription factor network—CD4—cervical cancer	0.000453	0.00584	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000428	0.00551	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000428	0.00551	CbGpPWpGaD
Cisplatin—SOD1—AGE/RAGE pathway—STAT3—cervical cancer	0.000415	0.00535	CbGpPWpGaD
Cisplatin—ABCB1—female reproductive system—cervical cancer	0.000414	0.00147	CbGeAlD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000413	0.00532	CbGpPWpGaD
Cisplatin—ABCC5—Fluoropyrimidine Activity—TP53—cervical cancer	0.000403	0.00519	CbGpPWpGaD
Cisplatin—PTGS2—lymph node—cervical cancer	0.000392	0.00139	CbGeAlD
Cisplatin—MPO—C-MYB transcription factor network—CD4—cervical cancer	0.000386	0.00497	CbGpPWpGaD
Cisplatin—SOD1—Copper homeostasis—TP53—cervical cancer	0.000383	0.00494	CbGpPWpGaD
Cisplatin—SOD1—AGE/RAGE pathway—EGFR—cervical cancer	0.000377	0.00486	CbGpPWpGaD
Cisplatin—ABCB1—female gonad—cervical cancer	0.000377	0.00134	CbGeAlD
Cisplatin—ABCB1—vagina—cervical cancer	0.000375	0.00133	CbGeAlD
Cisplatin—MT2A—Immune System—UBE3A—cervical cancer	0.000344	0.00443	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—TP53—cervical cancer	0.000317	0.00408	CbGpPWpGaD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000309	0.00398	CbGpPWpGaD
Cisplatin—ABCC3—Fluoropyrimidine Activity—TP53—cervical cancer	0.000297	0.00383	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—MTOR—cervical cancer	0.000294	0.00379	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—TP53—cervical cancer	0.000276	0.00356	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—CA9—cervical cancer	0.00026	0.00335	CbGpPWpGaD
Cisplatin—ABCB1—lymph node—cervical cancer	0.000242	0.000861	CbGeAlD
Cisplatin—ATP7A—Cellular responses to stress—STAT3—cervical cancer	0.000227	0.00293	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	0.000223	0.00287	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—HES1—cervical cancer	0.000222	0.00286	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000212	0.00273	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HLA-DPB1—cervical cancer	0.000205	0.00265	CbGpPWpGaD
Cisplatin—ABCG2—Fluoropyrimidine Activity—TP53—cervical cancer	0.000205	0.00264	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—STAT3—cervical cancer	0.000204	0.00263	CbGpPWpGaD
Cisplatin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	0.00019	0.00244	CbGpPWpGaD
Cisplatin—PTGS2—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000188	0.00242	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—MTOR—cervical cancer	0.000177	0.00228	CbGpPWpGaD
Cisplatin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—cervical cancer	0.000175	0.00225	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	0.000174	0.00224	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—TP53—cervical cancer	0.000173	0.00224	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—CA9—cervical cancer	0.000168	0.00216	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000167	0.00215	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HLA-DQB1—cervical cancer	0.00016	0.00207	CbGpPWpGaD
Cisplatin—BCHE—Peptide hormone metabolism—CTNNB1—cervical cancer	0.00016	0.00206	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—MTOR—cervical cancer	0.000155	0.00199	CbGpPWpGaD
Cisplatin—ABCC5—Disease—WNT2—cervical cancer	0.000151	0.00195	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00015	0.00193	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD8A—cervical cancer	0.00015	0.00193	CbGpPWpGaD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	0.000149	0.00192	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000143	0.00184	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—CA9—cervical cancer	0.000143	0.00184	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—CA9—cervical cancer	0.000139	0.00179	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—STAT3—cervical cancer	0.000137	0.00176	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—CD4—cervical cancer	0.000125	0.00161	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CA9—cervical cancer	0.000125	0.0016	CbGpPWpGaD
Cisplatin—MT2A—Immune System—FGFR3—cervical cancer	0.000123	0.00158	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CA9—cervical cancer	0.000119	0.00154	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—STAT3—cervical cancer	0.000119	0.00154	CbGpPWpGaD
Cisplatin—ABCC5—Disease—WNT5A—cervical cancer	0.000114	0.00147	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CASP8—cervical cancer	0.000114	0.00146	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—MTHFR—cervical cancer	0.000106	0.00136	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CASP8—cervical cancer	0.000105	0.00135	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—TP53—cervical cancer	0.000104	0.00135	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CA9—cervical cancer	0.000104	0.00133	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—TP53—cervical cancer	9.11e-05	0.00117	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CA9—cervical cancer	8.81e-05	0.00113	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CASP3—cervical cancer	8.79e-05	0.00113	CbGpPWpGaD
Cisplatin—MT2A—Immune System—MTOR—cervical cancer	8.62e-05	0.00111	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD4—cervical cancer	8.6e-05	0.00111	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CASP3—cervical cancer	8.59e-05	0.00111	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	7.91e-05	0.00102	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CTNNB1—cervical cancer	7.64e-05	0.000984	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—MTHFR—cervical cancer	6.8e-05	0.000876	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CA9—cervical cancer	6.73e-05	0.000867	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—EGFR—cervical cancer	6.72e-05	0.000865	CbGpPWpGaD
Cisplatin—MT2A—Immune System—STAT3—cervical cancer	6.66e-05	0.000858	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HES1—cervical cancer	6.59e-05	0.000849	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—cervical cancer	6.21e-05	0.0008	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CA9—cervical cancer	6.07e-05	0.000782	CbGpPWpGaD
Cisplatin—MT2A—Immune System—EGFR—cervical cancer	6.05e-05	0.00078	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CA9—cervical cancer	6.01e-05	0.000774	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	5.98e-05	0.000771	CbGpPWpGaD
Cisplatin—PTGS2—Disease—WNT2—cervical cancer	5.85e-05	0.000754	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MTHFR—cervical cancer	5.79e-05	0.000746	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—MTHFR—cervical cancer	5.78e-05	0.000745	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TERT—cervical cancer	5.77e-05	0.000744	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	5.77e-05	0.000743	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—cervical cancer	5.64e-05	0.000727	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—MTHFR—cervical cancer	5.64e-05	0.000726	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	5.6e-05	0.000722	CbGpPWpGaD
Cisplatin—ABCC5—Disease—FGFR3—cervical cancer	5.3e-05	0.000682	CbGpPWpGaD
Cisplatin—XDH—Metabolism—MTHFR—cervical cancer	5.06e-05	0.000651	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NOTCH1—cervical cancer	4.97e-05	0.000641	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—MTHFR—cervical cancer	4.85e-05	0.000624	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CA9—cervical cancer	4.63e-05	0.000597	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	4.57e-05	0.000589	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CA9—cervical cancer	4.45e-05	0.000573	CbGpPWpGaD
Cisplatin—PTGS2—Disease—WNT5A—cervical cancer	4.44e-05	0.000572	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	4.24e-05	0.000546	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—MTHFR—cervical cancer	4.2e-05	0.000541	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	4.09e-05	0.000527	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	3.84e-05	0.000494	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MTOR—cervical cancer	3.73e-05	0.00048	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CD4—cervical cancer	3.72e-05	0.000479	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—MTHFR—cervical cancer	3.57e-05	0.00046	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CTNNB1—cervical cancer	3.3e-05	0.000426	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CA9—cervical cancer	3.28e-05	0.000423	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	3.24e-05	0.000417	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CA9—cervical cancer	3.07e-05	0.000395	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CTNNB1—cervical cancer	3.02e-05	0.000389	CbGpPWpGaD
Cisplatin—ABCC5—Disease—STAT3—cervical cancer	2.88e-05	0.000371	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—MTHFR—cervical cancer	2.73e-05	0.000352	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	2.72e-05	0.00035	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EGFR—cervical cancer	2.62e-05	0.000337	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HES1—cervical cancer	2.55e-05	0.000329	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—MTHFR—cervical cancer	2.46e-05	0.000317	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—MTHFR—cervical cancer	2.44e-05	0.000314	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MTHFR—cervical cancer	2.24e-05	0.000289	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TERT—cervical cancer	2.24e-05	0.000288	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGFR3—cervical cancer	2.05e-05	0.000265	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NOTCH1—cervical cancer	1.93e-05	0.000248	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—MTHFR—cervical cancer	1.88e-05	0.000242	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—MTHFR—cervical cancer	1.81e-05	0.000233	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MTOR—cervical cancer	1.44e-05	0.000186	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD4—cervical cancer	1.44e-05	0.000186	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—MTHFR—cervical cancer	1.33e-05	0.000172	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CTNNB1—cervical cancer	1.28e-05	0.000165	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—MTHFR—cervical cancer	1.24e-05	0.00016	CbGpPWpGaD
Cisplatin—PTGS2—Disease—STAT3—cervical cancer	1.12e-05	0.000144	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—cervical cancer	1.01e-05	0.000131	CbGpPWpGaD
